Rajakumar Nagarajan1, Andres Saucedo 2, and M Albert Thomas2
1Human Magnetic Resonance Center, University of Massachusetts, Amherst MA, Amherst, MA, United States, 2Radiological Sciences, University of California Los Angeles, Los Angeles, CA, United States
Synopsis
Keywords: Liver, Spectroscopy
In vivo magnetic resonance spectroscopy has the potential to
provide information about both the quantity and composition of fat within the
liver. We have demonstrated the feasibility of detecting cross peaks using the
2D L-COSY technique at 3T in a healthy liver. This can be used to study fatty
liver to derive quantitative indexes.
Introduction
Proton (1H)
MRS has been evaluated in both research and clinical studies to assess liver
fat noninvasively in vivo (1,2). Non-invasive diagnostic techniques
for studying hepatobiliary pathology were investigated using MRS (3-5).
Fat and water are the most visible peaks in the one-dimensional (1D) MRS liver
spectrum obtained from the clinical MR scanners. While water shows a single
peak at approximately 4.7ppm, fat shows multiple peaks due to its complex
chemical components. Each peak of lipid spectra reflects unsaturated,
saturated, monounsaturated, and polyunsaturated fatty acids. The primary
advantages of two-dimensional localized correlated spectroscopy (2D L-COSY)
over 1D MRS are that connectivity between distinct individual spins is
delineated and J-coupled multiplet resonance peaks are spread over two
spectral dimensions (6,7). The degree of unsaturation measured noninvasively
may serve as a biomarker for lipid metabolic defects associated with pathology.
The present study aims to evaluate the use of 2D L-COSY to analyze lipid
composition in the liver in a healthy volunteer at 3T.Materials and Methods
Five healthy volunteers
(24.2 ± 3.2 yrs) participated in this study. MRS was performed on a 3T Siemens
Skyra scanner using the body coil for excitation, and an 18-channel phased array
combined with a spine matrix coil for signal reception. The MRS voxel was
positioned in the right hepatic lobe, avoiding the inclusion of the diaphragm
and edges of the liver and the vascular and biliary structures. Single voxel 1H
MRS was acquired during free-breathing, using a PRESS with the parameters TR
2000 ms, TE 30 ms, spectral bandwidth 2000 Hz, vector size 2048, voxel size
3x3x3cm3 (27cm3) with 128 averages (Scan time 4:30
min). The following parameters were used for 2D L-COSY: TR/TE=2000s/30ms,
3x3x3cm3, 2048 complex points, 8 averages per Δt1 and 64
Δt1 increments (Scan time=17:30min). 1D MRS data were processed
using jMRUI and all the metabolites and lipids were quantified using the AMARES
non-linear least squares algorithm, and 2D L-COSY data was processed with Felix
NMR software. Both 1D PRESS and 2D L-COSY peak integrals/volumes were presented
with respect to the 1.3 ppm lipid methylene peak (Fig.4A).Results
Fig.1 shows the 21 years
old healthy volunteer MRS voxel placement in the liver. Fig.2 shows liver 1D
MRS from the healthy volunteer with multiple peaks of lipids (0.9, 1.3, 2.09,
2.7, 4.30, and 5.3 ppm), trimethylamine (TMA) (3.12 ppm), and water (4.7 ppm).
Fig.3 shows the 2D L-COSY spectrum from a 21 years old healthy volunteer where
in addition to diagonal peaks from 1D MRS, there were few cross peaks (CP1 and
CP2) at (F2, F1= 2.0, 5.3 ppm) and (F2, F1=2.8,
5.3 ppm). Fig.4a compares the mean 1D and 2D L-COSY lipids peaks to 1.3 ppm,
and 4b shows the mean cross-peak volume obtained from 2D L-COSY. Both 1D PRESS
and 2D L-COSY data with respect to the 1.3 ppm lipid peak ranged from 0.04 to
0.39. We did not see significant changes in the lipids between 1D and 2D L-COSY
techniques (p>0.05).Discussion and Conclusions
This study
demonstrates the feasibility of detecting cross peaks using the 2D L-COSY
technique at 3T in a healthy liver. The volumes of the 2D cross-peak olefinic
protons at (5.3, 2.0 ppm) reflect monounsaturated fatty acid components, and
the cross-peak olefinic protons at (5.3, 2.8 ppm) reflect polyunsaturated fatty
acids. Ratios of these cross-peak volumes define the degree of unsaturation.
Thus, we propose that the 2D L-COSY-determined degree of unsaturation be
evaluated as a potential biomarker for lipid-based metabolic disturbances. A
drawback of this study is due to the lack of navigator echoes and cardiac gating to
minimize the motion-related effects, including higher standard deviation of
metabolite and lipid ratios. Further studies are required to explore the possibilities
of using the unsaturation index to scale the pathology's severity in clinical
practice 8-9. This technique needs further validation in more
subjects.Acknowledgements
We thank Elena Bliss, our MR Technologist, and Sean Doherty for
the jMRUI prior knowledge optimization.References
1.
Johnson NA, Walton DW, Sachinwalla T,
Thompson CH, Smith K, Ruell PA, Stannard SR, George J. Noninvasive assessment
of hepatic lipid composition: advancing understanding and management of fatty
liver disorders. Hepatology. 2008 May;47(5):1513-23.
2.
Hu HH, Kim HW, Nayak KS, Goran MI. Comparison
of fat–water MRI and single‐voxel
MRS in the assessment of hepatic and pancreatic fat fractions in humans.
Obesity. 2010 Apr;18(4):841-7.
3.
Jones JG. Non-Invasive Analysis of Human
Liver Metabolism by Magnetic Resonance Spectroscopy. Metabolites. 2021 Oct
29;11(11):751.
4.
Fischbach F, Bruhn H. Assessment of in vivo
1H magnetic resonance spectroscopy in the liver: a review. Liver International.
2008 Mar;28(3):297-307.
5.
Qayyum A. MR spectroscopy of the liver:
principles and clinical applications. Radiographics. 2009 Oct;29(6):1653.
6.
Thomas MA, Yue K, Binesh N, Davanzo P, Kumar
A, Siegel B, Frye M, Curran J, Lufkin R, Martin P, Guze B. Localized two‐dimensional shift correlated MR spectroscopy of
human brain. Magnetic Resonance in Medicine: An Official Journal of the
International Society for Magnetic Resonance in Medicine. 2001 Jul;46(1):58-67.
7.
Sarma MK, Huda A, Nagarajan R, Hinkin CH,
Wilson N, Gupta RK, Frias-Martinez E, Sayre J, Guze B, Han SH, Thomas MA.
Multi-dimensional MR spectroscopy: towards a better understanding of hepatic
encephalopathy. Metabolic brain disease. 2011 Sep;26(3):173-84.
8. Machann J, Stefan N, Wagner R, Bongers M, Schleicher E, Fritsche A, Häring HU, Nikolaou K, Schick F. Intra‐and interindividual variability of fatty acid unsaturation in six different human adipose tissue compartments assessed by 1H‐MRS in vivo at 3 T. NMR in Biomedicine. 2017 Sep;30(9):e3744.
9. Joy A, Saucedo A, Joines M, Lee-Felker S, Kumar S, Sarma MK, Sayre J, DiNome M, Thomas A. Correlated MR spectroscopic imaging of breast cancer to investigate metabolites and lipids: Acceleration and compressed sensing reconstruction. BJR Open. 2022;(1):20220009.